A novel mutation leading to a deletion in the SH3 domain of Bruton's tyrosine kinase
X-linked agammaglobulinemia (XLA) is a primary B cell immunodeficiency disorder, caused by a defect in the Bruton tyrosine kinase (BTK) gene. Here, we describe a novel four base pair mutation (838delGAGT) in intron 9 of the BTK gene leading to the skipping of exon 9 in a 2.5-year-old boy with...
Saved in:
| Main Authors: | Lütfiye Mesci, Hilal Ozdag, Tuba Turul, Fügen Ersoy, Ilhan Tezcan, Ozden Sanal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hacettepe University Institute of Child Health
2006-10-01
|
| Series: | The Turkish Journal of Pediatrics |
| Online Access: | https://turkjpediatr.org/article/view/2661 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bruton’s Tyrosine Kinase: A Double-Edged Sword in Cancer and Aging
by: Zahraa Qusairy, et al.
Published: (2025-05-01) -
The Potential Therapeutic Role of Bruton Tyrosine Kinase Inhibition in Neurodegenerative Diseases
by: Francesco D’Egidio, et al.
Published: (2025-07-01) -
Osteochondritis dissecans in a patient with hyperimmunoglobulin E syndrome
by: S Sebnem Kiliç, et al.
Published: (2002-10-01) -
The role of microglia in multiple sclerosis: implications for treatment with Bruton’s tyrosine kinase inhibitors
by: Patrick Vermersch, et al.
Published: (2025-05-01) -
Clinical features of chronic granulomatous disease: a series of 26 patients from a single center
by: Tuba Turul-Ozgür, et al.
Published: (2010-12-01)